Request Sample Inquiry
Infectious Disease Diagnostics Market

Infectious Disease Diagnostics Market

Infectious Disease Diagnostics Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

132

Base Year:

2022

Date

Mar - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1376

Segments Covered
  • By Product By Product Reagents, Kits, and Consumables, Instruments, Software & Services
  • By Type of Testing By Type of Testing Laboratory Testing, POC Testing
  • By Technology By Technology Immunodiagnostics, Clinical Microbiology , PCR , INAAT , DNA Sequencing & NGS , DNA Microarrays , Other technologies
  • By Disease Type By Disease Type COVID-19, HIV , HAIs , Hepatitis , CT/NG , HPV , TB , Influenza , Other Infectious Diseases
  • By End User By End User Diagnostic Laboratories, Hospitals & Clinics , Academic Research Institutes , Other End Users
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 29632.56 Million
Revenue 2030Revenue 2030: USD 49041.76 Million
Revenue CAGRRevenue CAGR (2023 - 2030): 6.50%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Research Methodology: Infectious Disease Diagnostics Market by Product by Type of Testing by Technology by Disease Type by End User - Global Market Assessment, 2021 - 2028

Secondary Research

Primary Research:

The next stage involves the primary research conducted to gather further information and revalidate the data collected from the secondary research. Moreover, primary research is also conducted to identify key players in the market and to gather their market-specific financial information. A typical primary interview fulfills data requirements pertaining to first-hand information global market size, regional and segmental trends, competitive landscape expertise development and market understandings among others. 

Data Triangulation and Market Size Estimations

Top-down and bottom-up approaches are used to validate and estimate the market size of the Infectious Disease Diagnostics market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. The data was triangulated by employing various data models and statistical techniques to arrive at exact statics and market size for each segment/sub-segment of the market.  

FAQ
Frequently Asked Question
  • The global Infectious Disease Diagnostics valued at USD 29632.56 Million in 2022 and is expected to reach USD 49041.76 Million in 2030 growing at a CAGR of 6.50%.

  • The prominent players in the market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd(Switzerland), bioMérieux SA (France), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Quidel Corporation(US), Hologic, Inc. (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Luminex Corporation (US), Meridian Bioscience (US), Genetic Signatures (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems, Inc. (US), Seegene Inc. (South Korea), Co-Diagnostics, Inc. (US), ELITechGroup (France), Epitope Diagnostics, Inc. (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International, Inc. (US), and ABACUS Diagnostica Oy (Finland)..

  • The market is project to grow at a CAGR of 6.50% between 2023 and 2030.

  • The driving factors of the Infectious Disease Diagnostics include

    • increasing prevalence of infectious diseases

  • North America was the leading regional segment of the Infectious Disease Diagnostics in 2022.